<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Supersized Ambitions: VentiRx Aims to be Extra-Large Player in Cancer, Allergy Medicines</title>
	<atom:link href="http://www.xconomy.com/seattle/2009/01/07/supersized-ambitions-ventirx-aims-to-be-extra-large-player-in-cancer-allergy-medicines/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/seattle/2009/01/07/supersized-ambitions-ventirx-aims-to-be-extra-large-player-in-cancer-allergy-medicines/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 21 Nov 2009 22:30:41 -0600</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: David Miller</title>
		<link>http://www.xconomy.com/seattle/2009/01/07/supersized-ambitions-ventirx-aims-to-be-extra-large-player-in-cancer-allergy-medicines/comment-page-1/#comment-44126</link>
		<dc:creator>David Miller</dc:creator>
		<pubDate>Wed, 07 Jan 2009 16:13:17 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=7315#comment-44126</guid>
		<description>Rob is one of the smartest biotech guys I know. VentiRx&#039;s approach is a potentially revolutionary one. There is great power and opportunity in the innate immune system and the first company to harness that will be a very valuable one.</description>
		<content:encoded><![CDATA[<p>Rob is one of the smartest biotech guys I know. VentiRx&#8217;s approach is a potentially revolutionary one. There is great power and opportunity in the innate immune system and the first company to harness that will be a very valuable one.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
